<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Hemasphere</journal-id>
    <journal-id journal-id-type="iso-abbrev">Hemasphere</journal-id>
    <journal-id journal-id-type="publisher-id">HS9</journal-id>
    <journal-title-group>
      <journal-title>HemaSphere</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2572-9241</issn>
    <publisher>
      <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
      <publisher-loc>Philadelphia, PA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10289560</article-id>
    <article-id pub-id-type="art-access-id">00004</article-id>
    <article-id pub-id-type="doi">10.1097/HS9.0000000000000922</article-id>
    <article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version>
    <article-categories>
      <subj-group subj-group-type="hwp-journal-coll">
        <subject>004</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Letter</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IthaPhen: An Interactive Database of Genotype-Phenotype Data for Hemoglobinopathies</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Xenophontos</surname>
          <given-names>Maria</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn01" ref-type="fn">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Minaidou</surname>
          <given-names>Anna</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn01" ref-type="fn">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stephanou</surname>
          <given-names>Coralea</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tamana</surname>
          <given-names>Stella</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kleanthous</surname>
          <given-names>Marina</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn02" ref-type="fn">**</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Kountouris</surname>
          <given-names>Petros</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn02" ref-type="fn">**</xref>
      </contrib>
      <aff id="aff1"><label>1</label>Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus</aff>
    </contrib-group>
    <author-notes>
      <corresp id="c1"><bold>Correspondence:</bold> Petros Kountouris (<email xlink:href="petrosk@cing.ac.cy">petrosk@cing.ac.cy</email>).</corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>22</day>
      <month>6</month>
      <year>2023</year>
    </pub-date>
    <volume>7</volume>
    <issue>7</issue>
    <elocation-id>e922</elocation-id>
    <history>
      <date date-type="received">
        <day>07</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>31</day>
        <month>5</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License</ext-link>, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="hs9-7-e922.pdf"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>OPEN-ACCESS</meta-name>
        <meta-value>TRUE</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>SDC</meta-name>
        <meta-value>T</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <p>Hemoglobinopathies are the commonest monogenic diseases, with ≈6% of the world’s population carrying a pathogenic globin gene variant.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> To date, &gt;2400 disease-causing variants have been reported in the IthaGenes database,<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> with various severity and clinical presentation.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Nevertheless, most of these variants are rare and their functional impact is unclear. The use of case-level data and subsequent genotype-phenotype correlations can enhance our understanding of the pathophysiological mechanisms of hemoglobinopathies and can assist their diagnosis and clinical management. In fact, the evaluation of case-level data is a critical component of both the general framework for standardized variant classification<sup><xref rid="R6" ref-type="bibr">6</xref></sup> by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) and the specified rules currently developed by the ClinGen Hemoglobinopathy Variant Curation Expert Panel (VCEP).<sup><xref rid="R7" ref-type="bibr">7</xref></sup> However, large amounts of case-level data remain unexploited as they reside in the databases of diagnostic laboratories and/or the publications they produce. The utility of genome-wide databases such as ClinVar,<sup><xref rid="R8" ref-type="bibr">8</xref></sup> DECIPHER,<sup><xref rid="R9" ref-type="bibr">9</xref></sup> and the ClinGen Variant Curation Interface<sup><xref rid="R10" ref-type="bibr">10</xref></sup> in hemoglobinopathies is also limited due to the low number of variants for the globin genes. Notably, hemoglobinopathy-specific databases, such as HbVar<sup><xref rid="R11" ref-type="bibr">11</xref></sup> and IthaGenes, provide limited phenotypic information for a small fraction of curated variants in tabular or text format, impeding their use for further analysis and variant interpretation. Hence, the development of a comprehensive, curated genotype-phenotype database is an urgent need to bring together available molecular and clinical information published in scientific literature or residing in diagnostic and clinical laboratories.</p>
  <p>Herein, we present IthaPhen, a manually curated, searchable, and intuitive database of public anonymized case reports linked to hemoglobinopathies. IthaPhen integrates genotypic data with hematological, biochemical, histological, and clinical data and, through search queries of user-defined genotypes, returns both the primary case-level data and aggregated, visualized reports.</p>
  <p>We considered globin gene variants annotated in IthaGenes<sup><xref rid="R3" ref-type="bibr">3</xref></sup> and collected individual case reports with such variants, through a rigorous literature search. We excluded articles providing only aggregated descriptions of specific cohorts, as IthaPhen does not currently support cohort descriptions. In addition, direct contributions of anonymized, previously unpublished case-level data were accepted through the ITHANET submission process and contributions were acknowledged throughout the ITHANET portal.</p>
  <p>We collected demographic information, including age, sex, ethnicity and, if available, the individual’s relationship with the proband. Furthermore, a rigorous literature search was performed for the selection of phenotypic parameters that are frequently reported and more relevant to hemoglobinopathies. The phenotypic parameters were expanded accordingly throughout the development period. Currently, IthaPhen collects a total of 86 phenotypic parameters, organized in 13 categories: blood transfusion (2), hematological investigation (12), biochemical investigation (3), biosynthetic ratio (4), hemoglobin profile (9), erythrocyte inclusions (2), hemoglobin properties (7), red blood cell morphology/microscopy (11), anemia (6), diagnostic imaging (2), clinical findings (25), clinical classification (2), and the miscellaneous other test category. The complete list of data parameters and their definitions are available in <ext-link xlink:href="http://links.lww.com/HS/A440" ext-link-type="uri">Suppl. File 1</ext-link>. Moreover, the European Molecular Genetics Quality Network (EMQN) best practice guidelines<sup><xref rid="R12" ref-type="bibr">12</xref></sup> have been integrated with IthaPhen to provide recommendations about prenatal or preimplantation genetic diagnosis, depending on the user-defined genotype query.</p>
  <p>IthaPhen is developed using a relational database management system based on MySQL and PHP and is fully integrated and interconnected with the existing infrastructure of the ITHANET portal.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> The content curation of IthaPhen is included in the existing ITHANET curation strategy with weekly updates, as previously described<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> and documented in the ITHANET FAQ page (<ext-link xlink:href="https://www.ithanet.eu/home/faqs" ext-link-type="uri">https://www.ithanet.eu/home/faqs</ext-link>), thus ensuring the sustainability and relevance of the database.</p>
  <p>At the time of writing, IthaPhen contains data for 3997 cases (3853 published and 144 contributed), collected from 764 publications and 28 contributors, while it stores information for 588 families (ie, ≥2 related cases). These cases cover 850 unique globin gene variants, representing over 34% of all variants annotated as causative in IthaGenes. IthaPhen provides a diverse set of case-level data in terms of demographics, genotype, and phenotype. Specifically, Figure <xref rid="F1" ref-type="fig">1</xref> illustrates the distribution of cases according to the reported ethnicity; grouped by the top-level definitions of the Human Ancestry Ontology<sup><xref rid="R14" ref-type="bibr">14</xref></sup> (Figure <xref rid="F1" ref-type="fig">1</xref>A), sex and age (Figure <xref rid="F1" ref-type="fig">1</xref>B), genotypes (Figure <xref rid="F1" ref-type="fig">1</xref>C), and phenotypic annotation (Figure <xref rid="F1" ref-type="fig">1</xref>D–<xref rid="F1" ref-type="fig">1</xref>E). Most cases are examined at least with respect to the hemoglobin profile (eg, hemoglobin [Hb] A2) or other hematological aspects (eg, Hb, mean corpuscular volume [MCV], and mean corpuscular hemoglobin [MCH]), but clinical characterization is also prevalent.</p>
  <fig position="float" id="F1">
    <label>Figure 1.</label>
    <caption>
      <p><bold>Distribution of IthaPhen entries.</bold> (A) Characterization of the origin of individuals reported in IthaPhen according to the Human Ancestry Ontology. Individuals whose origin was not specified by the curated reports, are shown here under the category Unknown. (B) Age and sex distribution of cases reported on IthaPhen. (C) Percentage of homozygous, heterozygous, and compound heterozygous cases per globin loci. (D–E) The phenotypic parameters collected in IthaPhen and their grouping into categories.</p>
    </caption>
    <graphic xlink:href="hs9-7-e922-g001" position="float"/>
  </fig>
  <p>The visualization interface is highly intuitive, user-friendly, and informative, and is illustrated in <ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1</ext-link> for an example query (--<sup>SEA</sup>/αα). IthaPhen supports queries of any genotype combination, including heterozygous, compound heterozygous, or homozygous individuals, as well as combinations of genotypes in both globin loci. Filtering based on genotype gives the option to select a specific variant or allele phenotype (eg, β<sup>+</sup>, α<sup>0</sup>) for each allele (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1A</ext-link>). Apart from the minimally required genotype filter, IthaPhen also allows further filtering by age and sex. The query results include summary statistics of the phenotype of matching cases presented as tables and graphs (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1B and S1C</ext-link>, respectively), but also the raw case data. All summary data produced per queried information can be downloaded as a report, while all raw data for each search can also be downloaded in the Unified Dataset section. Along with the query results, IthaPhen additionally delivers links to relevant queries involving variants in the user’s primary search (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1D</ext-link>). Importantly, all relevant EMQN best practice guidelines are also reported,<sup><xref rid="R12" ref-type="bibr">12</xref></sup> as to provide recommendations on prenatal or preimplantation genetic diagnosis, for genotypes that may occur in the offspring of individuals with the queried genotype (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1E</ext-link>). Finally, the result section also lists all sources used in curating the individual cases from publications or direct contributions.</p>
  <p>The IthaPhen dataset is freely available for noncommercial use and further analysis. Herein, we demonstrate its use with 2 examples. First, we investigate phenotypic differences in deletional hereditary persistence of fetal hemoglobin (HPFH) and δβ-thalassemia, two molecularly similar conditions characterized by elevated fetal hemoglobin (Hb F) levels. In heterozygotes, their diagnosis is challenging as it strongly depends on hematological indices and empirical differences in the Hb F levels.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Using case-level data stored in IthaPhen, we performed a series of logistic regression models (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>) to demonstrate a quantitative approach in the diagnosis of the 2 conditions. Hb F and MCV are differently distributed between δβ-thalassemia and deletional HPFH (Figure <xref rid="F1" ref-type="fig">1</xref>A) and were found to be predictive of δβ-thalassemia diagnosis, with odds ratio 0.83 (95% confidence interval [CI], 0.748-0.902) and 0.84 (95% CI, 0.57-0.913), respectively (Figure <xref rid="F2" ref-type="fig">2</xref>B). Likelihood ratios (LRs) are often employed to create a clinically applicable assessment of a patient’s clinical image and aid in selecting further appropriate diagnostic test, while LRs have been widely used in variant classification.<sup><xref rid="R16" ref-type="bibr">16</xref>–<xref rid="R18" ref-type="bibr">18</xref></sup> Thus, we also assessed the LR estimates for these predictors of δβ-thalassemia diagnosis (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>). Significantly higher LRs are observed for low MCV values (&lt;75fL) and HbF &lt;15%, indicating δβ-thalassemia diagnosis, while significantly lower LRs are observed for normal/borderline MCV values and HbF &gt;20% (Figure <xref rid="F2" ref-type="fig">2</xref>C).</p>
  <fig position="float" id="F2">
    <label>Figure 2.</label>
    <caption>
      <p><bold>Genotype-phenotype correlation for δβ-thalassemia and deletional HPFH.</bold> (A) Distribution of Hb F and MCV measurements in δβ-thalassemia and deletional HPFH. (B) Odds ratio for parameters identified as significant predictors in the logistic regression model. <italic toggle="yes">P</italic> values &lt;0.001 are annotated with 3 asterisks. (C) Likelihood ratio estimates for δβ-thalassemia per hematological indices class. Hb F = fetal hemoglobin; HPFH = hereditary persistence of fetal hemoglobin.</p>
    </caption>
    <graphic xlink:href="hs9-7-e922-g002" position="float"/>
  </fig>
  <p>The second example is the use of IthaPhen data for variant interpretation through the evaluation of case-level and segregation data. Here, we demonstrate how such data collected on IthaPhen can be used under the ACMG/AMP framework for globin genes, specified by the ClinGen Hemoglobinopathy VCEP,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> to assess variant pathogenicity. As shown in <ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>: (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. Table S2</ext-link>), 3 globin gene variants currently classified as variants of uncertain significance in ClinVar have been enriched with case-level and segregation evidence organized in IthaPhen, specifically for ACMG/AMP-specified criteria PM3, PM6, PS4, and PP1, resulting in a more informative interpretation.</p>
  <p>IthaPhen is a novel disease-specific genotype-phenotype database that aims to uncover the case-level evidence that is fragmented in scientific literature or remains unexploited in diagnostic laboratories, particularly for rare hemoglobinopathy cases. It collects anonymized published and contributed genotype-phenotype data and brings together available molecular, laboratory, and clinical information. IthaPhen demonstrates the correlations between genotype and phenotype and is a unique and powerful tool for clinicians and molecular geneticists.</p>
  <p>The integration of IthaPhen with other databases of the constantly updated ITHANET portal provides the community with a valuable expanding dataset of case-level data with rich phenotypic annotation and ensures its sustainability. In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies. Notably, we demonstrated the utility of IthaPhen with 2 examples in (a) genotype-phenotype correlation and (b) standardized variant classification, illustrating how IthaPhen can contribute to data-driven and quantitative approaches in the field of hemoglobinopathies.</p>
  <p>IthaPhen is currently focused on the annotation of case-level and segregation evidence particularly for less common variants that, due to their frequency, represent the most challenging cases for diagnostic laboratories. However, in the future, we plan to also incorporate data from studies reporting aggregated cohort descriptions and larger amounts of disease-modifying variants.<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup> This will potentially contribute to the personalized diagnosis and management of hemoglobinopathies.</p>
  <sec>
    <title>ACKNOWLEDGMENTS</title>
    <p>We thank the Cyprus Institute of Neurology and Genetics for computer equipment and for hosting ITHANET. We owe particular thanks to Kyriaki Michailidou for the many fruitful discussions and advisory on the statistical analyses presented herein.</p>
  </sec>
  <sec>
    <title>AUTHOR CONTRIBUTIONS</title>
    <p>MX, AM, PK, and MK conceived and designed the study. MX designed and developed the database and tool interface. AM defined the data parameters to be collected. MX analyzed the data and produced the figures. AM, CS, and ST curated and validated data. ST designed the FAQ section. MX, AM, and PK wrote the article. All authors have read and approved the final version of the article.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>DATA AVAILABILITY STATEMENT</title>
    <p>IthaPhen and all associated data are available via a web interface at <ext-link xlink:href="https://ithanet.eu/db/ithaphen" ext-link-type="uri">https://ithanet.eu/db/ithaphen</ext-link>. We make the source code for running the analyses and generating the figures presented herein, freely available at <ext-link xlink:href="https://github.com/cing-mgt/ithaphen-db-analysis" ext-link-type="uri">https://github.com/cing-mgt/ithaphen-db-analysis</ext-link>.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>DISCLOSURES</title>
    <p>The authors have no conflicts of interest to disclose.</p>
  </sec>
  <sec>
    <title>SOURCES OF FUNDING</title>
    <p>This work is cofunded by the European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation (Project: EXCELLENCE/1216/256).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="SD1" position="float" content-type="local-data">
      <media id="s1" content-type="document" xlink:href="hs9-7-e922-s001.xlsx" position="anchor"/>
      <media id="s2" content-type="document" xlink:href="hs9-7-e922-s002.pdf" position="anchor"/>
      <media id="s3" content-type="document" xlink:href="hs9-7-e922-s003.pdf" position="anchor"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <fn-group>
    <fn fn-type="equal" id="fn01">
      <label>*</label>
      <p>MX and AM shared joint first authorship.</p>
    </fn>
    <fn fn-type="equal" id="fn02">
      <label>**</label>
      <p>MK and PK shared joint last authorship.</p>
    </fn>
    <fn fn-type="supplementary-material">
      <p>Supplemental digital content is available for this article.</p>
    </fn>
  </fn-group>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modell</surname><given-names>B</given-names></name><name><surname>Darlison</surname><given-names>M</given-names></name></person-group>. <article-title>Global epidemiology of haemoglobin disorders and derived service indicators.</article-title><source>Bull World Health Organ</source>. <year>2008</year>;<volume>86</volume>:<fpage>480</fpage>–<lpage>487</lpage>.<pub-id pub-id-type="pmid">18568278</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><collab>GBD 2019 Diseases and Injuries Collaborators</collab>. <article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</article-title><source>Lancet</source>. <year>2020</year>;<volume>396</volume>:<fpage>1204</fpage>–<lpage>1222</lpage>.<pub-id pub-id-type="pmid">33069326</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Lederer</surname><given-names>CW</given-names></name><name><surname>Fanis</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>IthaGenes: an interactive database for haemoglobin variations and epidemiology.</article-title><source>PLoS One</source>. <year>2014</year>;<volume>9</volume>:<fpage>e103020</fpage>.<pub-id pub-id-type="pmid">25058394</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Bento</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>ITHANET: information and database community portal for haemoglobinopathies.</article-title><source>bioRxiv</source>. <year>2017</year>:<fpage>209361</fpage>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Michailidou</surname><given-names>K</given-names></name><name><surname>Christou</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.</article-title><source>Haematologica</source>. <year>2021</year>;<volume>106</volume>:<fpage>2458</fpage>–<lpage>2468</lpage>.<pub-id pub-id-type="pmid">32732363</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Bale</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.</article-title><source>Genet Med</source>. <year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Lederer</surname><given-names>CW</given-names></name><etal/></person-group>. <article-title>Adapting the ACMG/AMP variant classification framework: a perspective from the clingen hemoglobinopathy variant curation expert panel.</article-title><source>Hum Mutat</source>. <year>2022</year>;<volume>43</volume>:<fpage>1089</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">34510646</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landrum</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Riley</surname><given-names>GR</given-names></name><etal/></person-group>. <article-title>ClinVar: public archive of relationships among sequence variation and human phenotype.</article-title><source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>:<fpage>D980</fpage>–<lpage>D985</lpage>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firth</surname><given-names>HV</given-names></name><name><surname>Richards</surname><given-names>SM</given-names></name><name><surname>Bevan</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources.</article-title><source>Am J Hum Genet</source>. <year>2009</year>;<volume>84</volume>:<fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">19344873</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preston</surname><given-names>CG</given-names></name><name><surname>Wright</surname><given-names>MW</given-names></name><name><surname>Madhavrao</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>ClinGen variant curation interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines.</article-title><source>Genome Med</source>. <year>2022</year>;<volume>14</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">35039090</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giardine</surname><given-names>BM</given-names></name><name><surname>Joly</surname><given-names>P</given-names></name><name><surname>Pissard</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations.</article-title><source>Nucleic Acids Res</source>. <year>2021</year>;<volume>49</volume>(<issue>D1</issue>):<fpage>D1192</fpage>–<lpage>D1196</lpage>.<pub-id pub-id-type="pmid">33125055</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traeger-Synodinos</surname><given-names>J</given-names></name><name><surname>Harteveld</surname><given-names>CL</given-names></name><name><surname>Old</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>EMQN best practice guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.</article-title><source>Eur J Hum Genet</source>. <year>2015</year>;<volume>23</volume>:<fpage>426</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">25052315</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederer</surname><given-names>CW</given-names></name><name><surname>Basak</surname><given-names>AN</given-names></name><name><surname>Aydinok</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.</article-title><source>Hemoglobin</source>. <year>2009</year>;<volume>33</volume>:<fpage>163</fpage>–<lpage>176</lpage>.<pub-id pub-id-type="pmid">19657830</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>J</given-names></name><name><surname>Welter</surname><given-names>D</given-names></name><name><surname>Bowler</surname><given-names>EH</given-names></name><etal/></person-group>. <article-title>A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog.</article-title><source>Genome Biol</source>. <year>2018</year>;<volume>19</volume>:<fpage>21</fpage>.<pub-id pub-id-type="pmid">29448949</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minaidou</surname><given-names>A</given-names></name><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>A novel tool for the analysis and detection of copy number variants associated with haemoglobinopathies.</article-title><source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>:<fpage>15920</fpage>.<pub-id pub-id-type="pmid">36555557</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spurdle</surname><given-names>AB</given-names></name><name><surname>Couch</surname><given-names>FJ</given-names></name><name><surname>Parsons</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.</article-title><source>Breast Cancer Res</source>. <year>2014</year>;<volume>16</volume>:<fpage>3419</fpage>.<pub-id pub-id-type="pmid">25857409</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavtigian</surname><given-names>SV</given-names></name><name><surname>Greenblatt</surname><given-names>MS</given-names></name><name><surname>Harrison</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.</article-title><source>Genet Med</source>. <year>2018</year>;<volume>20</volume>:<fpage>1054</fpage>–<lpage>1060</lpage>.<pub-id pub-id-type="pmid">29300386</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Xenophontos</surname><given-names>M</given-names></name><name><surname>Minaidou</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.</article-title><source>Elife</source>. <year>2022</year>;<volume>11</volume>:<fpage>e79713</fpage>.<pub-id pub-id-type="pmid">36453528</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehipour</surname><given-names>D</given-names></name><name><surname>Farncombe</surname><given-names>KM</given-names></name><name><surname>Andric</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is.</article-title><source>Database</source>. <year>2023</year>;<volume>2023</volume>:<fpage>baac109</fpage>.<pub-id pub-id-type="pmid">36617168</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Minaidou</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Genetic modifiers at the crossroads of personalised medicine for haemoglobinopathies.</article-title><source>J Clin Med</source>. <year>2019</year>;<volume>8</volume>:<fpage>1927</fpage>.<pub-id pub-id-type="pmid">31717530</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Archer</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies.</article-title><source>Am J Hematol</source>. <year>2021</year>;<volume>96</volume>:<fpage>E416</fpage>–<lpage>E420</lpage>.<pub-id pub-id-type="pmid">34406671</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Hemasphere</journal-id>
    <journal-id journal-id-type="iso-abbrev">Hemasphere</journal-id>
    <journal-id journal-id-type="publisher-id">HS9</journal-id>
    <journal-title-group>
      <journal-title>HemaSphere</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2572-9241</issn>
    <publisher>
      <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
      <publisher-loc>Philadelphia, PA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10289560</article-id>
    <article-id pub-id-type="art-access-id">00004</article-id>
    <article-id pub-id-type="doi">10.1097/HS9.0000000000000922</article-id>
    <article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version>
    <article-categories>
      <subj-group subj-group-type="hwp-journal-coll">
        <subject>004</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Letter</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IthaPhen: An Interactive Database of Genotype-Phenotype Data for Hemoglobinopathies</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Xenophontos</surname>
          <given-names>Maria</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn01" ref-type="fn">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Minaidou</surname>
          <given-names>Anna</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn01" ref-type="fn">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stephanou</surname>
          <given-names>Coralea</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tamana</surname>
          <given-names>Stella</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kleanthous</surname>
          <given-names>Marina</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn02" ref-type="fn">**</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Kountouris</surname>
          <given-names>Petros</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn02" ref-type="fn">**</xref>
      </contrib>
      <aff id="aff1"><label>1</label>Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus</aff>
    </contrib-group>
    <author-notes>
      <corresp id="c1"><bold>Correspondence:</bold> Petros Kountouris (<email xlink:href="petrosk@cing.ac.cy">petrosk@cing.ac.cy</email>).</corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>22</day>
      <month>6</month>
      <year>2023</year>
    </pub-date>
    <volume>7</volume>
    <issue>7</issue>
    <elocation-id>e922</elocation-id>
    <history>
      <date date-type="received">
        <day>07</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>31</day>
        <month>5</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License</ext-link>, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="hs9-7-e922.pdf"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>OPEN-ACCESS</meta-name>
        <meta-value>TRUE</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>SDC</meta-name>
        <meta-value>T</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <p>Hemoglobinopathies are the commonest monogenic diseases, with ≈6% of the world’s population carrying a pathogenic globin gene variant.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> To date, &gt;2400 disease-causing variants have been reported in the IthaGenes database,<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> with various severity and clinical presentation.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Nevertheless, most of these variants are rare and their functional impact is unclear. The use of case-level data and subsequent genotype-phenotype correlations can enhance our understanding of the pathophysiological mechanisms of hemoglobinopathies and can assist their diagnosis and clinical management. In fact, the evaluation of case-level data is a critical component of both the general framework for standardized variant classification<sup><xref rid="R6" ref-type="bibr">6</xref></sup> by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) and the specified rules currently developed by the ClinGen Hemoglobinopathy Variant Curation Expert Panel (VCEP).<sup><xref rid="R7" ref-type="bibr">7</xref></sup> However, large amounts of case-level data remain unexploited as they reside in the databases of diagnostic laboratories and/or the publications they produce. The utility of genome-wide databases such as ClinVar,<sup><xref rid="R8" ref-type="bibr">8</xref></sup> DECIPHER,<sup><xref rid="R9" ref-type="bibr">9</xref></sup> and the ClinGen Variant Curation Interface<sup><xref rid="R10" ref-type="bibr">10</xref></sup> in hemoglobinopathies is also limited due to the low number of variants for the globin genes. Notably, hemoglobinopathy-specific databases, such as HbVar<sup><xref rid="R11" ref-type="bibr">11</xref></sup> and IthaGenes, provide limited phenotypic information for a small fraction of curated variants in tabular or text format, impeding their use for further analysis and variant interpretation. Hence, the development of a comprehensive, curated genotype-phenotype database is an urgent need to bring together available molecular and clinical information published in scientific literature or residing in diagnostic and clinical laboratories.</p>
  <p>Herein, we present IthaPhen, a manually curated, searchable, and intuitive database of public anonymized case reports linked to hemoglobinopathies. IthaPhen integrates genotypic data with hematological, biochemical, histological, and clinical data and, through search queries of user-defined genotypes, returns both the primary case-level data and aggregated, visualized reports.</p>
  <p>We considered globin gene variants annotated in IthaGenes<sup><xref rid="R3" ref-type="bibr">3</xref></sup> and collected individual case reports with such variants, through a rigorous literature search. We excluded articles providing only aggregated descriptions of specific cohorts, as IthaPhen does not currently support cohort descriptions. In addition, direct contributions of anonymized, previously unpublished case-level data were accepted through the ITHANET submission process and contributions were acknowledged throughout the ITHANET portal.</p>
  <p>We collected demographic information, including age, sex, ethnicity and, if available, the individual’s relationship with the proband. Furthermore, a rigorous literature search was performed for the selection of phenotypic parameters that are frequently reported and more relevant to hemoglobinopathies. The phenotypic parameters were expanded accordingly throughout the development period. Currently, IthaPhen collects a total of 86 phenotypic parameters, organized in 13 categories: blood transfusion (2), hematological investigation (12), biochemical investigation (3), biosynthetic ratio (4), hemoglobin profile (9), erythrocyte inclusions (2), hemoglobin properties (7), red blood cell morphology/microscopy (11), anemia (6), diagnostic imaging (2), clinical findings (25), clinical classification (2), and the miscellaneous other test category. The complete list of data parameters and their definitions are available in <ext-link xlink:href="http://links.lww.com/HS/A440" ext-link-type="uri">Suppl. File 1</ext-link>. Moreover, the European Molecular Genetics Quality Network (EMQN) best practice guidelines<sup><xref rid="R12" ref-type="bibr">12</xref></sup> have been integrated with IthaPhen to provide recommendations about prenatal or preimplantation genetic diagnosis, depending on the user-defined genotype query.</p>
  <p>IthaPhen is developed using a relational database management system based on MySQL and PHP and is fully integrated and interconnected with the existing infrastructure of the ITHANET portal.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> The content curation of IthaPhen is included in the existing ITHANET curation strategy with weekly updates, as previously described<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> and documented in the ITHANET FAQ page (<ext-link xlink:href="https://www.ithanet.eu/home/faqs" ext-link-type="uri">https://www.ithanet.eu/home/faqs</ext-link>), thus ensuring the sustainability and relevance of the database.</p>
  <p>At the time of writing, IthaPhen contains data for 3997 cases (3853 published and 144 contributed), collected from 764 publications and 28 contributors, while it stores information for 588 families (ie, ≥2 related cases). These cases cover 850 unique globin gene variants, representing over 34% of all variants annotated as causative in IthaGenes. IthaPhen provides a diverse set of case-level data in terms of demographics, genotype, and phenotype. Specifically, Figure <xref rid="F1" ref-type="fig">1</xref> illustrates the distribution of cases according to the reported ethnicity; grouped by the top-level definitions of the Human Ancestry Ontology<sup><xref rid="R14" ref-type="bibr">14</xref></sup> (Figure <xref rid="F1" ref-type="fig">1</xref>A), sex and age (Figure <xref rid="F1" ref-type="fig">1</xref>B), genotypes (Figure <xref rid="F1" ref-type="fig">1</xref>C), and phenotypic annotation (Figure <xref rid="F1" ref-type="fig">1</xref>D–<xref rid="F1" ref-type="fig">1</xref>E). Most cases are examined at least with respect to the hemoglobin profile (eg, hemoglobin [Hb] A2) or other hematological aspects (eg, Hb, mean corpuscular volume [MCV], and mean corpuscular hemoglobin [MCH]), but clinical characterization is also prevalent.</p>
  <fig position="float" id="F1">
    <label>Figure 1.</label>
    <caption>
      <p><bold>Distribution of IthaPhen entries.</bold> (A) Characterization of the origin of individuals reported in IthaPhen according to the Human Ancestry Ontology. Individuals whose origin was not specified by the curated reports, are shown here under the category Unknown. (B) Age and sex distribution of cases reported on IthaPhen. (C) Percentage of homozygous, heterozygous, and compound heterozygous cases per globin loci. (D–E) The phenotypic parameters collected in IthaPhen and their grouping into categories.</p>
    </caption>
    <graphic xlink:href="hs9-7-e922-g001" position="float"/>
  </fig>
  <p>The visualization interface is highly intuitive, user-friendly, and informative, and is illustrated in <ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1</ext-link> for an example query (--<sup>SEA</sup>/αα). IthaPhen supports queries of any genotype combination, including heterozygous, compound heterozygous, or homozygous individuals, as well as combinations of genotypes in both globin loci. Filtering based on genotype gives the option to select a specific variant or allele phenotype (eg, β<sup>+</sup>, α<sup>0</sup>) for each allele (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1A</ext-link>). Apart from the minimally required genotype filter, IthaPhen also allows further filtering by age and sex. The query results include summary statistics of the phenotype of matching cases presented as tables and graphs (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1B and S1C</ext-link>, respectively), but also the raw case data. All summary data produced per queried information can be downloaded as a report, while all raw data for each search can also be downloaded in the Unified Dataset section. Along with the query results, IthaPhen additionally delivers links to relevant queries involving variants in the user’s primary search (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1D</ext-link>). Importantly, all relevant EMQN best practice guidelines are also reported,<sup><xref rid="R12" ref-type="bibr">12</xref></sup> as to provide recommendations on prenatal or preimplantation genetic diagnosis, for genotypes that may occur in the offspring of individuals with the queried genotype (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1E</ext-link>). Finally, the result section also lists all sources used in curating the individual cases from publications or direct contributions.</p>
  <p>The IthaPhen dataset is freely available for noncommercial use and further analysis. Herein, we demonstrate its use with 2 examples. First, we investigate phenotypic differences in deletional hereditary persistence of fetal hemoglobin (HPFH) and δβ-thalassemia, two molecularly similar conditions characterized by elevated fetal hemoglobin (Hb F) levels. In heterozygotes, their diagnosis is challenging as it strongly depends on hematological indices and empirical differences in the Hb F levels.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Using case-level data stored in IthaPhen, we performed a series of logistic regression models (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>) to demonstrate a quantitative approach in the diagnosis of the 2 conditions. Hb F and MCV are differently distributed between δβ-thalassemia and deletional HPFH (Figure <xref rid="F1" ref-type="fig">1</xref>A) and were found to be predictive of δβ-thalassemia diagnosis, with odds ratio 0.83 (95% confidence interval [CI], 0.748-0.902) and 0.84 (95% CI, 0.57-0.913), respectively (Figure <xref rid="F2" ref-type="fig">2</xref>B). Likelihood ratios (LRs) are often employed to create a clinically applicable assessment of a patient’s clinical image and aid in selecting further appropriate diagnostic test, while LRs have been widely used in variant classification.<sup><xref rid="R16" ref-type="bibr">16</xref>–<xref rid="R18" ref-type="bibr">18</xref></sup> Thus, we also assessed the LR estimates for these predictors of δβ-thalassemia diagnosis (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>). Significantly higher LRs are observed for low MCV values (&lt;75fL) and HbF &lt;15%, indicating δβ-thalassemia diagnosis, while significantly lower LRs are observed for normal/borderline MCV values and HbF &gt;20% (Figure <xref rid="F2" ref-type="fig">2</xref>C).</p>
  <fig position="float" id="F2">
    <label>Figure 2.</label>
    <caption>
      <p><bold>Genotype-phenotype correlation for δβ-thalassemia and deletional HPFH.</bold> (A) Distribution of Hb F and MCV measurements in δβ-thalassemia and deletional HPFH. (B) Odds ratio for parameters identified as significant predictors in the logistic regression model. <italic toggle="yes">P</italic> values &lt;0.001 are annotated with 3 asterisks. (C) Likelihood ratio estimates for δβ-thalassemia per hematological indices class. Hb F = fetal hemoglobin; HPFH = hereditary persistence of fetal hemoglobin.</p>
    </caption>
    <graphic xlink:href="hs9-7-e922-g002" position="float"/>
  </fig>
  <p>The second example is the use of IthaPhen data for variant interpretation through the evaluation of case-level and segregation data. Here, we demonstrate how such data collected on IthaPhen can be used under the ACMG/AMP framework for globin genes, specified by the ClinGen Hemoglobinopathy VCEP,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> to assess variant pathogenicity. As shown in <ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>: (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. Table S2</ext-link>), 3 globin gene variants currently classified as variants of uncertain significance in ClinVar have been enriched with case-level and segregation evidence organized in IthaPhen, specifically for ACMG/AMP-specified criteria PM3, PM6, PS4, and PP1, resulting in a more informative interpretation.</p>
  <p>IthaPhen is a novel disease-specific genotype-phenotype database that aims to uncover the case-level evidence that is fragmented in scientific literature or remains unexploited in diagnostic laboratories, particularly for rare hemoglobinopathy cases. It collects anonymized published and contributed genotype-phenotype data and brings together available molecular, laboratory, and clinical information. IthaPhen demonstrates the correlations between genotype and phenotype and is a unique and powerful tool for clinicians and molecular geneticists.</p>
  <p>The integration of IthaPhen with other databases of the constantly updated ITHANET portal provides the community with a valuable expanding dataset of case-level data with rich phenotypic annotation and ensures its sustainability. In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies. Notably, we demonstrated the utility of IthaPhen with 2 examples in (a) genotype-phenotype correlation and (b) standardized variant classification, illustrating how IthaPhen can contribute to data-driven and quantitative approaches in the field of hemoglobinopathies.</p>
  <p>IthaPhen is currently focused on the annotation of case-level and segregation evidence particularly for less common variants that, due to their frequency, represent the most challenging cases for diagnostic laboratories. However, in the future, we plan to also incorporate data from studies reporting aggregated cohort descriptions and larger amounts of disease-modifying variants.<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup> This will potentially contribute to the personalized diagnosis and management of hemoglobinopathies.</p>
  <sec>
    <title>ACKNOWLEDGMENTS</title>
    <p>We thank the Cyprus Institute of Neurology and Genetics for computer equipment and for hosting ITHANET. We owe particular thanks to Kyriaki Michailidou for the many fruitful discussions and advisory on the statistical analyses presented herein.</p>
  </sec>
  <sec>
    <title>AUTHOR CONTRIBUTIONS</title>
    <p>MX, AM, PK, and MK conceived and designed the study. MX designed and developed the database and tool interface. AM defined the data parameters to be collected. MX analyzed the data and produced the figures. AM, CS, and ST curated and validated data. ST designed the FAQ section. MX, AM, and PK wrote the article. All authors have read and approved the final version of the article.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>DATA AVAILABILITY STATEMENT</title>
    <p>IthaPhen and all associated data are available via a web interface at <ext-link xlink:href="https://ithanet.eu/db/ithaphen" ext-link-type="uri">https://ithanet.eu/db/ithaphen</ext-link>. We make the source code for running the analyses and generating the figures presented herein, freely available at <ext-link xlink:href="https://github.com/cing-mgt/ithaphen-db-analysis" ext-link-type="uri">https://github.com/cing-mgt/ithaphen-db-analysis</ext-link>.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>DISCLOSURES</title>
    <p>The authors have no conflicts of interest to disclose.</p>
  </sec>
  <sec>
    <title>SOURCES OF FUNDING</title>
    <p>This work is cofunded by the European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation (Project: EXCELLENCE/1216/256).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="SD1" position="float" content-type="local-data">
      <media id="s1" content-type="document" xlink:href="hs9-7-e922-s001.xlsx" position="anchor"/>
      <media id="s2" content-type="document" xlink:href="hs9-7-e922-s002.pdf" position="anchor"/>
      <media id="s3" content-type="document" xlink:href="hs9-7-e922-s003.pdf" position="anchor"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <fn-group>
    <fn fn-type="equal" id="fn01">
      <label>*</label>
      <p>MX and AM shared joint first authorship.</p>
    </fn>
    <fn fn-type="equal" id="fn02">
      <label>**</label>
      <p>MK and PK shared joint last authorship.</p>
    </fn>
    <fn fn-type="supplementary-material">
      <p>Supplemental digital content is available for this article.</p>
    </fn>
  </fn-group>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modell</surname><given-names>B</given-names></name><name><surname>Darlison</surname><given-names>M</given-names></name></person-group>. <article-title>Global epidemiology of haemoglobin disorders and derived service indicators.</article-title><source>Bull World Health Organ</source>. <year>2008</year>;<volume>86</volume>:<fpage>480</fpage>–<lpage>487</lpage>.<pub-id pub-id-type="pmid">18568278</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><collab>GBD 2019 Diseases and Injuries Collaborators</collab>. <article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</article-title><source>Lancet</source>. <year>2020</year>;<volume>396</volume>:<fpage>1204</fpage>–<lpage>1222</lpage>.<pub-id pub-id-type="pmid">33069326</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Lederer</surname><given-names>CW</given-names></name><name><surname>Fanis</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>IthaGenes: an interactive database for haemoglobin variations and epidemiology.</article-title><source>PLoS One</source>. <year>2014</year>;<volume>9</volume>:<fpage>e103020</fpage>.<pub-id pub-id-type="pmid">25058394</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Bento</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>ITHANET: information and database community portal for haemoglobinopathies.</article-title><source>bioRxiv</source>. <year>2017</year>:<fpage>209361</fpage>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Michailidou</surname><given-names>K</given-names></name><name><surname>Christou</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.</article-title><source>Haematologica</source>. <year>2021</year>;<volume>106</volume>:<fpage>2458</fpage>–<lpage>2468</lpage>.<pub-id pub-id-type="pmid">32732363</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Bale</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.</article-title><source>Genet Med</source>. <year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Lederer</surname><given-names>CW</given-names></name><etal/></person-group>. <article-title>Adapting the ACMG/AMP variant classification framework: a perspective from the clingen hemoglobinopathy variant curation expert panel.</article-title><source>Hum Mutat</source>. <year>2022</year>;<volume>43</volume>:<fpage>1089</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">34510646</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landrum</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Riley</surname><given-names>GR</given-names></name><etal/></person-group>. <article-title>ClinVar: public archive of relationships among sequence variation and human phenotype.</article-title><source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>:<fpage>D980</fpage>–<lpage>D985</lpage>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firth</surname><given-names>HV</given-names></name><name><surname>Richards</surname><given-names>SM</given-names></name><name><surname>Bevan</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources.</article-title><source>Am J Hum Genet</source>. <year>2009</year>;<volume>84</volume>:<fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">19344873</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preston</surname><given-names>CG</given-names></name><name><surname>Wright</surname><given-names>MW</given-names></name><name><surname>Madhavrao</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>ClinGen variant curation interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines.</article-title><source>Genome Med</source>. <year>2022</year>;<volume>14</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">35039090</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giardine</surname><given-names>BM</given-names></name><name><surname>Joly</surname><given-names>P</given-names></name><name><surname>Pissard</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations.</article-title><source>Nucleic Acids Res</source>. <year>2021</year>;<volume>49</volume>(<issue>D1</issue>):<fpage>D1192</fpage>–<lpage>D1196</lpage>.<pub-id pub-id-type="pmid">33125055</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traeger-Synodinos</surname><given-names>J</given-names></name><name><surname>Harteveld</surname><given-names>CL</given-names></name><name><surname>Old</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>EMQN best practice guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.</article-title><source>Eur J Hum Genet</source>. <year>2015</year>;<volume>23</volume>:<fpage>426</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">25052315</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederer</surname><given-names>CW</given-names></name><name><surname>Basak</surname><given-names>AN</given-names></name><name><surname>Aydinok</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.</article-title><source>Hemoglobin</source>. <year>2009</year>;<volume>33</volume>:<fpage>163</fpage>–<lpage>176</lpage>.<pub-id pub-id-type="pmid">19657830</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>J</given-names></name><name><surname>Welter</surname><given-names>D</given-names></name><name><surname>Bowler</surname><given-names>EH</given-names></name><etal/></person-group>. <article-title>A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog.</article-title><source>Genome Biol</source>. <year>2018</year>;<volume>19</volume>:<fpage>21</fpage>.<pub-id pub-id-type="pmid">29448949</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minaidou</surname><given-names>A</given-names></name><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>A novel tool for the analysis and detection of copy number variants associated with haemoglobinopathies.</article-title><source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>:<fpage>15920</fpage>.<pub-id pub-id-type="pmid">36555557</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spurdle</surname><given-names>AB</given-names></name><name><surname>Couch</surname><given-names>FJ</given-names></name><name><surname>Parsons</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.</article-title><source>Breast Cancer Res</source>. <year>2014</year>;<volume>16</volume>:<fpage>3419</fpage>.<pub-id pub-id-type="pmid">25857409</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavtigian</surname><given-names>SV</given-names></name><name><surname>Greenblatt</surname><given-names>MS</given-names></name><name><surname>Harrison</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.</article-title><source>Genet Med</source>. <year>2018</year>;<volume>20</volume>:<fpage>1054</fpage>–<lpage>1060</lpage>.<pub-id pub-id-type="pmid">29300386</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Xenophontos</surname><given-names>M</given-names></name><name><surname>Minaidou</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.</article-title><source>Elife</source>. <year>2022</year>;<volume>11</volume>:<fpage>e79713</fpage>.<pub-id pub-id-type="pmid">36453528</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehipour</surname><given-names>D</given-names></name><name><surname>Farncombe</surname><given-names>KM</given-names></name><name><surname>Andric</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is.</article-title><source>Database</source>. <year>2023</year>;<volume>2023</volume>:<fpage>baac109</fpage>.<pub-id pub-id-type="pmid">36617168</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Minaidou</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Genetic modifiers at the crossroads of personalised medicine for haemoglobinopathies.</article-title><source>J Clin Med</source>. <year>2019</year>;<volume>8</volume>:<fpage>1927</fpage>.<pub-id pub-id-type="pmid">31717530</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Archer</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies.</article-title><source>Am J Hematol</source>. <year>2021</year>;<volume>96</volume>:<fpage>E416</fpage>–<lpage>E420</lpage>.<pub-id pub-id-type="pmid">34406671</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Hemasphere</journal-id>
    <journal-id journal-id-type="iso-abbrev">Hemasphere</journal-id>
    <journal-id journal-id-type="publisher-id">HS9</journal-id>
    <journal-title-group>
      <journal-title>HemaSphere</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2572-9241</issn>
    <publisher>
      <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
      <publisher-loc>Philadelphia, PA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10289560</article-id>
    <article-id pub-id-type="art-access-id">00004</article-id>
    <article-id pub-id-type="doi">10.1097/HS9.0000000000000922</article-id>
    <article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version>
    <article-categories>
      <subj-group subj-group-type="hwp-journal-coll">
        <subject>004</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Letter</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IthaPhen: An Interactive Database of Genotype-Phenotype Data for Hemoglobinopathies</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Xenophontos</surname>
          <given-names>Maria</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn01" ref-type="fn">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Minaidou</surname>
          <given-names>Anna</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn01" ref-type="fn">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stephanou</surname>
          <given-names>Coralea</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tamana</surname>
          <given-names>Stella</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kleanthous</surname>
          <given-names>Marina</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn02" ref-type="fn">**</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Kountouris</surname>
          <given-names>Petros</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn02" ref-type="fn">**</xref>
      </contrib>
      <aff id="aff1"><label>1</label>Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus</aff>
    </contrib-group>
    <author-notes>
      <corresp id="c1"><bold>Correspondence:</bold> Petros Kountouris (<email xlink:href="petrosk@cing.ac.cy">petrosk@cing.ac.cy</email>).</corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>22</day>
      <month>6</month>
      <year>2023</year>
    </pub-date>
    <volume>7</volume>
    <issue>7</issue>
    <elocation-id>e922</elocation-id>
    <history>
      <date date-type="received">
        <day>07</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>31</day>
        <month>5</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License</ext-link>, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="hs9-7-e922.pdf"/>
    <custom-meta-group>
      <custom-meta>
        <meta-name>OPEN-ACCESS</meta-name>
        <meta-value>TRUE</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>SDC</meta-name>
        <meta-value>T</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <p>Hemoglobinopathies are the commonest monogenic diseases, with ≈6% of the world’s population carrying a pathogenic globin gene variant.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> To date, &gt;2400 disease-causing variants have been reported in the IthaGenes database,<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> with various severity and clinical presentation.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Nevertheless, most of these variants are rare and their functional impact is unclear. The use of case-level data and subsequent genotype-phenotype correlations can enhance our understanding of the pathophysiological mechanisms of hemoglobinopathies and can assist their diagnosis and clinical management. In fact, the evaluation of case-level data is a critical component of both the general framework for standardized variant classification<sup><xref rid="R6" ref-type="bibr">6</xref></sup> by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) and the specified rules currently developed by the ClinGen Hemoglobinopathy Variant Curation Expert Panel (VCEP).<sup><xref rid="R7" ref-type="bibr">7</xref></sup> However, large amounts of case-level data remain unexploited as they reside in the databases of diagnostic laboratories and/or the publications they produce. The utility of genome-wide databases such as ClinVar,<sup><xref rid="R8" ref-type="bibr">8</xref></sup> DECIPHER,<sup><xref rid="R9" ref-type="bibr">9</xref></sup> and the ClinGen Variant Curation Interface<sup><xref rid="R10" ref-type="bibr">10</xref></sup> in hemoglobinopathies is also limited due to the low number of variants for the globin genes. Notably, hemoglobinopathy-specific databases, such as HbVar<sup><xref rid="R11" ref-type="bibr">11</xref></sup> and IthaGenes, provide limited phenotypic information for a small fraction of curated variants in tabular or text format, impeding their use for further analysis and variant interpretation. Hence, the development of a comprehensive, curated genotype-phenotype database is an urgent need to bring together available molecular and clinical information published in scientific literature or residing in diagnostic and clinical laboratories.</p>
  <p>Herein, we present IthaPhen, a manually curated, searchable, and intuitive database of public anonymized case reports linked to hemoglobinopathies. IthaPhen integrates genotypic data with hematological, biochemical, histological, and clinical data and, through search queries of user-defined genotypes, returns both the primary case-level data and aggregated, visualized reports.</p>
  <p>We considered globin gene variants annotated in IthaGenes<sup><xref rid="R3" ref-type="bibr">3</xref></sup> and collected individual case reports with such variants, through a rigorous literature search. We excluded articles providing only aggregated descriptions of specific cohorts, as IthaPhen does not currently support cohort descriptions. In addition, direct contributions of anonymized, previously unpublished case-level data were accepted through the ITHANET submission process and contributions were acknowledged throughout the ITHANET portal.</p>
  <p>We collected demographic information, including age, sex, ethnicity and, if available, the individual’s relationship with the proband. Furthermore, a rigorous literature search was performed for the selection of phenotypic parameters that are frequently reported and more relevant to hemoglobinopathies. The phenotypic parameters were expanded accordingly throughout the development period. Currently, IthaPhen collects a total of 86 phenotypic parameters, organized in 13 categories: blood transfusion (2), hematological investigation (12), biochemical investigation (3), biosynthetic ratio (4), hemoglobin profile (9), erythrocyte inclusions (2), hemoglobin properties (7), red blood cell morphology/microscopy (11), anemia (6), diagnostic imaging (2), clinical findings (25), clinical classification (2), and the miscellaneous other test category. The complete list of data parameters and their definitions are available in <ext-link xlink:href="http://links.lww.com/HS/A440" ext-link-type="uri">Suppl. File 1</ext-link>. Moreover, the European Molecular Genetics Quality Network (EMQN) best practice guidelines<sup><xref rid="R12" ref-type="bibr">12</xref></sup> have been integrated with IthaPhen to provide recommendations about prenatal or preimplantation genetic diagnosis, depending on the user-defined genotype query.</p>
  <p>IthaPhen is developed using a relational database management system based on MySQL and PHP and is fully integrated and interconnected with the existing infrastructure of the ITHANET portal.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> The content curation of IthaPhen is included in the existing ITHANET curation strategy with weekly updates, as previously described<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup> and documented in the ITHANET FAQ page (<ext-link xlink:href="https://www.ithanet.eu/home/faqs" ext-link-type="uri">https://www.ithanet.eu/home/faqs</ext-link>), thus ensuring the sustainability and relevance of the database.</p>
  <p>At the time of writing, IthaPhen contains data for 3997 cases (3853 published and 144 contributed), collected from 764 publications and 28 contributors, while it stores information for 588 families (ie, ≥2 related cases). These cases cover 850 unique globin gene variants, representing over 34% of all variants annotated as causative in IthaGenes. IthaPhen provides a diverse set of case-level data in terms of demographics, genotype, and phenotype. Specifically, Figure <xref rid="F1" ref-type="fig">1</xref> illustrates the distribution of cases according to the reported ethnicity; grouped by the top-level definitions of the Human Ancestry Ontology<sup><xref rid="R14" ref-type="bibr">14</xref></sup> (Figure <xref rid="F1" ref-type="fig">1</xref>A), sex and age (Figure <xref rid="F1" ref-type="fig">1</xref>B), genotypes (Figure <xref rid="F1" ref-type="fig">1</xref>C), and phenotypic annotation (Figure <xref rid="F1" ref-type="fig">1</xref>D–<xref rid="F1" ref-type="fig">1</xref>E). Most cases are examined at least with respect to the hemoglobin profile (eg, hemoglobin [Hb] A2) or other hematological aspects (eg, Hb, mean corpuscular volume [MCV], and mean corpuscular hemoglobin [MCH]), but clinical characterization is also prevalent.</p>
  <fig position="float" id="F1">
    <label>Figure 1.</label>
    <caption>
      <p><bold>Distribution of IthaPhen entries.</bold> (A) Characterization of the origin of individuals reported in IthaPhen according to the Human Ancestry Ontology. Individuals whose origin was not specified by the curated reports, are shown here under the category Unknown. (B) Age and sex distribution of cases reported on IthaPhen. (C) Percentage of homozygous, heterozygous, and compound heterozygous cases per globin loci. (D–E) The phenotypic parameters collected in IthaPhen and their grouping into categories.</p>
    </caption>
    <graphic xlink:href="hs9-7-e922-g001" position="float"/>
  </fig>
  <p>The visualization interface is highly intuitive, user-friendly, and informative, and is illustrated in <ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1</ext-link> for an example query (--<sup>SEA</sup>/αα). IthaPhen supports queries of any genotype combination, including heterozygous, compound heterozygous, or homozygous individuals, as well as combinations of genotypes in both globin loci. Filtering based on genotype gives the option to select a specific variant or allele phenotype (eg, β<sup>+</sup>, α<sup>0</sup>) for each allele (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1A</ext-link>). Apart from the minimally required genotype filter, IthaPhen also allows further filtering by age and sex. The query results include summary statistics of the phenotype of matching cases presented as tables and graphs (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1B and S1C</ext-link>, respectively), but also the raw case data. All summary data produced per queried information can be downloaded as a report, while all raw data for each search can also be downloaded in the Unified Dataset section. Along with the query results, IthaPhen additionally delivers links to relevant queries involving variants in the user’s primary search (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1D</ext-link>). Importantly, all relevant EMQN best practice guidelines are also reported,<sup><xref rid="R12" ref-type="bibr">12</xref></sup> as to provide recommendations on prenatal or preimplantation genetic diagnosis, for genotypes that may occur in the offspring of individuals with the queried genotype (<ext-link xlink:href="http://links.lww.com/HS/A442" ext-link-type="uri">Suppl. Figure S1E</ext-link>). Finally, the result section also lists all sources used in curating the individual cases from publications or direct contributions.</p>
  <p>The IthaPhen dataset is freely available for noncommercial use and further analysis. Herein, we demonstrate its use with 2 examples. First, we investigate phenotypic differences in deletional hereditary persistence of fetal hemoglobin (HPFH) and δβ-thalassemia, two molecularly similar conditions characterized by elevated fetal hemoglobin (Hb F) levels. In heterozygotes, their diagnosis is challenging as it strongly depends on hematological indices and empirical differences in the Hb F levels.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Using case-level data stored in IthaPhen, we performed a series of logistic regression models (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>) to demonstrate a quantitative approach in the diagnosis of the 2 conditions. Hb F and MCV are differently distributed between δβ-thalassemia and deletional HPFH (Figure <xref rid="F1" ref-type="fig">1</xref>A) and were found to be predictive of δβ-thalassemia diagnosis, with odds ratio 0.83 (95% confidence interval [CI], 0.748-0.902) and 0.84 (95% CI, 0.57-0.913), respectively (Figure <xref rid="F2" ref-type="fig">2</xref>B). Likelihood ratios (LRs) are often employed to create a clinically applicable assessment of a patient’s clinical image and aid in selecting further appropriate diagnostic test, while LRs have been widely used in variant classification.<sup><xref rid="R16" ref-type="bibr">16</xref>–<xref rid="R18" ref-type="bibr">18</xref></sup> Thus, we also assessed the LR estimates for these predictors of δβ-thalassemia diagnosis (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>). Significantly higher LRs are observed for low MCV values (&lt;75fL) and HbF &lt;15%, indicating δβ-thalassemia diagnosis, while significantly lower LRs are observed for normal/borderline MCV values and HbF &gt;20% (Figure <xref rid="F2" ref-type="fig">2</xref>C).</p>
  <fig position="float" id="F2">
    <label>Figure 2.</label>
    <caption>
      <p><bold>Genotype-phenotype correlation for δβ-thalassemia and deletional HPFH.</bold> (A) Distribution of Hb F and MCV measurements in δβ-thalassemia and deletional HPFH. (B) Odds ratio for parameters identified as significant predictors in the logistic regression model. <italic toggle="yes">P</italic> values &lt;0.001 are annotated with 3 asterisks. (C) Likelihood ratio estimates for δβ-thalassemia per hematological indices class. Hb F = fetal hemoglobin; HPFH = hereditary persistence of fetal hemoglobin.</p>
    </caption>
    <graphic xlink:href="hs9-7-e922-g002" position="float"/>
  </fig>
  <p>The second example is the use of IthaPhen data for variant interpretation through the evaluation of case-level and segregation data. Here, we demonstrate how such data collected on IthaPhen can be used under the ACMG/AMP framework for globin genes, specified by the ClinGen Hemoglobinopathy VCEP,<sup><xref rid="R7" ref-type="bibr">7</xref></sup> to assess variant pathogenicity. As shown in <ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. File 2</ext-link>: (<ext-link xlink:href="http://links.lww.com/HS/A441" ext-link-type="uri">Suppl. Table S2</ext-link>), 3 globin gene variants currently classified as variants of uncertain significance in ClinVar have been enriched with case-level and segregation evidence organized in IthaPhen, specifically for ACMG/AMP-specified criteria PM3, PM6, PS4, and PP1, resulting in a more informative interpretation.</p>
  <p>IthaPhen is a novel disease-specific genotype-phenotype database that aims to uncover the case-level evidence that is fragmented in scientific literature or remains unexploited in diagnostic laboratories, particularly for rare hemoglobinopathy cases. It collects anonymized published and contributed genotype-phenotype data and brings together available molecular, laboratory, and clinical information. IthaPhen demonstrates the correlations between genotype and phenotype and is a unique and powerful tool for clinicians and molecular geneticists.</p>
  <p>The integration of IthaPhen with other databases of the constantly updated ITHANET portal provides the community with a valuable expanding dataset of case-level data with rich phenotypic annotation and ensures its sustainability. In addition, it will help generate critical evidence for the interpretation of globin gene variants based on the ACMG/AMP framework, an approach also followed by other VCEPs.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Furthermore, the integration of EMQN guidelines into IthaPhen facilitates, but does not replace, genetic diagnosis and genetic counseling for hemoglobinopathies, particularly in countries with limited experience and less exposure to hemoglobinopathies. Notably, we demonstrated the utility of IthaPhen with 2 examples in (a) genotype-phenotype correlation and (b) standardized variant classification, illustrating how IthaPhen can contribute to data-driven and quantitative approaches in the field of hemoglobinopathies.</p>
  <p>IthaPhen is currently focused on the annotation of case-level and segregation evidence particularly for less common variants that, due to their frequency, represent the most challenging cases for diagnostic laboratories. However, in the future, we plan to also incorporate data from studies reporting aggregated cohort descriptions and larger amounts of disease-modifying variants.<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup> This will potentially contribute to the personalized diagnosis and management of hemoglobinopathies.</p>
  <sec>
    <title>ACKNOWLEDGMENTS</title>
    <p>We thank the Cyprus Institute of Neurology and Genetics for computer equipment and for hosting ITHANET. We owe particular thanks to Kyriaki Michailidou for the many fruitful discussions and advisory on the statistical analyses presented herein.</p>
  </sec>
  <sec>
    <title>AUTHOR CONTRIBUTIONS</title>
    <p>MX, AM, PK, and MK conceived and designed the study. MX designed and developed the database and tool interface. AM defined the data parameters to be collected. MX analyzed the data and produced the figures. AM, CS, and ST curated and validated data. ST designed the FAQ section. MX, AM, and PK wrote the article. All authors have read and approved the final version of the article.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>DATA AVAILABILITY STATEMENT</title>
    <p>IthaPhen and all associated data are available via a web interface at <ext-link xlink:href="https://ithanet.eu/db/ithaphen" ext-link-type="uri">https://ithanet.eu/db/ithaphen</ext-link>. We make the source code for running the analyses and generating the figures presented herein, freely available at <ext-link xlink:href="https://github.com/cing-mgt/ithaphen-db-analysis" ext-link-type="uri">https://github.com/cing-mgt/ithaphen-db-analysis</ext-link>.</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>DISCLOSURES</title>
    <p>The authors have no conflicts of interest to disclose.</p>
  </sec>
  <sec>
    <title>SOURCES OF FUNDING</title>
    <p>This work is cofunded by the European Regional Development Fund and the Republic of Cyprus through the Research and Innovation Foundation (Project: EXCELLENCE/1216/256).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="SD1" position="float" content-type="local-data">
      <media id="s1" content-type="document" xlink:href="hs9-7-e922-s001.xlsx" position="anchor"/>
      <media id="s2" content-type="document" xlink:href="hs9-7-e922-s002.pdf" position="anchor"/>
      <media id="s3" content-type="document" xlink:href="hs9-7-e922-s003.pdf" position="anchor"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <fn-group>
    <fn fn-type="equal" id="fn01">
      <label>*</label>
      <p>MX and AM shared joint first authorship.</p>
    </fn>
    <fn fn-type="equal" id="fn02">
      <label>**</label>
      <p>MK and PK shared joint last authorship.</p>
    </fn>
    <fn fn-type="supplementary-material">
      <p>Supplemental digital content is available for this article.</p>
    </fn>
  </fn-group>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modell</surname><given-names>B</given-names></name><name><surname>Darlison</surname><given-names>M</given-names></name></person-group>. <article-title>Global epidemiology of haemoglobin disorders and derived service indicators.</article-title><source>Bull World Health Organ</source>. <year>2008</year>;<volume>86</volume>:<fpage>480</fpage>–<lpage>487</lpage>.<pub-id pub-id-type="pmid">18568278</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><collab>GBD 2019 Diseases and Injuries Collaborators</collab>. <article-title>Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</article-title><source>Lancet</source>. <year>2020</year>;<volume>396</volume>:<fpage>1204</fpage>–<lpage>1222</lpage>.<pub-id pub-id-type="pmid">33069326</pub-id></mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Lederer</surname><given-names>CW</given-names></name><name><surname>Fanis</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>IthaGenes: an interactive database for haemoglobin variations and epidemiology.</article-title><source>PLoS One</source>. <year>2014</year>;<volume>9</volume>:<fpage>e103020</fpage>.<pub-id pub-id-type="pmid">25058394</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Bento</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>ITHANET: information and database community portal for haemoglobinopathies.</article-title><source>bioRxiv</source>. <year>2017</year>:<fpage>209361</fpage>.</mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Michailidou</surname><given-names>K</given-names></name><name><surname>Christou</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.</article-title><source>Haematologica</source>. <year>2021</year>;<volume>106</volume>:<fpage>2458</fpage>–<lpage>2468</lpage>.<pub-id pub-id-type="pmid">32732363</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Bale</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.</article-title><source>Genet Med</source>. <year>2015</year>;<volume>17</volume>:<fpage>405</fpage>–<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Lederer</surname><given-names>CW</given-names></name><etal/></person-group>. <article-title>Adapting the ACMG/AMP variant classification framework: a perspective from the clingen hemoglobinopathy variant curation expert panel.</article-title><source>Hum Mutat</source>. <year>2022</year>;<volume>43</volume>:<fpage>1089</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">34510646</pub-id></mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landrum</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Riley</surname><given-names>GR</given-names></name><etal/></person-group>. <article-title>ClinVar: public archive of relationships among sequence variation and human phenotype.</article-title><source>Nucleic Acids Res</source>. <year>2014</year>;<volume>42</volume>:<fpage>D980</fpage>–<lpage>D985</lpage>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firth</surname><given-names>HV</given-names></name><name><surname>Richards</surname><given-names>SM</given-names></name><name><surname>Bevan</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>DECIPHER: database of chromosomal imbalance and phenotype in humans using Ensembl resources.</article-title><source>Am J Hum Genet</source>. <year>2009</year>;<volume>84</volume>:<fpage>524</fpage>–<lpage>533</lpage>.<pub-id pub-id-type="pmid">19344873</pub-id></mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preston</surname><given-names>CG</given-names></name><name><surname>Wright</surname><given-names>MW</given-names></name><name><surname>Madhavrao</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>ClinGen variant curation interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines.</article-title><source>Genome Med</source>. <year>2022</year>;<volume>14</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">35039090</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giardine</surname><given-names>BM</given-names></name><name><surname>Joly</surname><given-names>P</given-names></name><name><surname>Pissard</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations.</article-title><source>Nucleic Acids Res</source>. <year>2021</year>;<volume>49</volume>(<issue>D1</issue>):<fpage>D1192</fpage>–<lpage>D1196</lpage>.<pub-id pub-id-type="pmid">33125055</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traeger-Synodinos</surname><given-names>J</given-names></name><name><surname>Harteveld</surname><given-names>CL</given-names></name><name><surname>Old</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>EMQN best practice guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies.</article-title><source>Eur J Hum Genet</source>. <year>2015</year>;<volume>23</volume>:<fpage>426</fpage>–<lpage>437</lpage>.<pub-id pub-id-type="pmid">25052315</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederer</surname><given-names>CW</given-names></name><name><surname>Basak</surname><given-names>AN</given-names></name><name><surname>Aydinok</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.</article-title><source>Hemoglobin</source>. <year>2009</year>;<volume>33</volume>:<fpage>163</fpage>–<lpage>176</lpage>.<pub-id pub-id-type="pmid">19657830</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>J</given-names></name><name><surname>Welter</surname><given-names>D</given-names></name><name><surname>Bowler</surname><given-names>EH</given-names></name><etal/></person-group>. <article-title>A standardized framework for representation of ancestry data in genomics studies, with application to the NHGRI-EBI GWAS Catalog.</article-title><source>Genome Biol</source>. <year>2018</year>;<volume>19</volume>:<fpage>21</fpage>.<pub-id pub-id-type="pmid">29448949</pub-id></mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minaidou</surname><given-names>A</given-names></name><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>A novel tool for the analysis and detection of copy number variants associated with haemoglobinopathies.</article-title><source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>:<fpage>15920</fpage>.<pub-id pub-id-type="pmid">36555557</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spurdle</surname><given-names>AB</given-names></name><name><surname>Couch</surname><given-names>FJ</given-names></name><name><surname>Parsons</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.</article-title><source>Breast Cancer Res</source>. <year>2014</year>;<volume>16</volume>:<fpage>3419</fpage>.<pub-id pub-id-type="pmid">25857409</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tavtigian</surname><given-names>SV</given-names></name><name><surname>Greenblatt</surname><given-names>MS</given-names></name><name><surname>Harrison</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.</article-title><source>Genet Med</source>. <year>2018</year>;<volume>20</volume>:<fpage>1054</fpage>–<lpage>1060</lpage>.<pub-id pub-id-type="pmid">29300386</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Xenophontos</surname><given-names>M</given-names></name><name><surname>Minaidou</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Evaluation of in silico predictors on short nucleotide variants in HBA1, HBA2, and HBB associated with haemoglobinopathies.</article-title><source>Elife</source>. <year>2022</year>;<volume>11</volume>:<fpage>e79713</fpage>.<pub-id pub-id-type="pmid">36453528</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehipour</surname><given-names>D</given-names></name><name><surname>Farncombe</surname><given-names>KM</given-names></name><name><surname>Andric</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is.</article-title><source>Database</source>. <year>2023</year>;<volume>2023</volume>:<fpage>baac109</fpage>.<pub-id pub-id-type="pmid">36617168</pub-id></mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Tamana</surname><given-names>S</given-names></name><name><surname>Minaidou</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Genetic modifiers at the crossroads of personalised medicine for haemoglobinopathies.</article-title><source>J Clin Med</source>. <year>2019</year>;<volume>8</volume>:<fpage>1927</fpage>.<pub-id pub-id-type="pmid">31717530</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kountouris</surname><given-names>P</given-names></name><name><surname>Stephanou</surname><given-names>C</given-names></name><name><surname>Archer</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies.</article-title><source>Am J Hematol</source>. <year>2021</year>;<volume>96</volume>:<fpage>E416</fpage>–<lpage>E420</lpage>.<pub-id pub-id-type="pmid">34406671</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
